FindTrial
Sign In

A study to analyse the efficacy of the Uva Ursi Q, 6C and 30C in treating urinary tract infections

A Comparative study between the Uva Ursi Q, 6C and 30C in the efficacy of treating urinary tract infections - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073727
Enrollment
30
Registered
2024-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Uva Ursi Q: Uva Ursi Tincture Orally will be given to the patients of Group A and Follow up will be taken and urine Microscopy will be done after 2 days Control Intervention1: Uva Ursi

Sponsors

Vinayaka Missions Homoeopathic Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis should be confirmed with urinary microscopic analysis.(Pus Cells more than 10/HPF)

Exclusion criteria

Exclusion criteria: Secondary UTIs should not be included. Those who are under antibiotic therapy Immunocompromised Patients

Design outcomes

Primary

MeasureTime frame
To Know the variation between action of Uva Ursi Tincture, 6C and 30C in the treatment of Urinary Tract InfectionTimepoint: from first day of case taking where initial assesment with urine microscopy will be done and reassessment will be done 2days later symptomatically and with urine microscopy—

Secondary

MeasureTime frame
To verify and demonstrate the efficacy of Uva Ursi Homoeopathic Preparation in treatment of UTITimepoint: 2 Days—

Countries

India

Contacts

Public ContactDr Santi Dheepan
santiagobear93@gmail.com9986076195

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026